Back

Prognostic value of right ventricular to pulmonary artery coupling in transthyretin amyloid cardiomyopathy

9 May 2026 (12:30 - 13:30)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (1) Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Emidio Mata

Alto Ave Hospital Center, Guimaraes (Portugal)

7 More presentations in this session

Presentation thumbnail
Non-dilated left ventricular cardiomyopathy at the early stages of chronic chagas disease
Professor R. Bestetti (Ribeirao Preto, BR)
Abstract Slides
Presentation thumbnail
Pre-diagnostic red flags and referral pathways in transthyretin cardiac amyloidosis: correlation with disease stage and outcomes.
Doctor M. Iseppi (Trento, IT)
Abstract Slides
Presentation thumbnail
Device-pocket subcutaneous fat sampling for amyloid screening in elderly patients undergoing cardiac device implantation
Doctor T. Capovilla (Rovereto, IT)
Abstract Slides
Presentation thumbnail
Cardiomyopathy detection using ensemble-based segmentation and radiomics
Doctor T. Tsampras (Athens, GR)
Abstract Slides
Presentation thumbnail
Right ventricular-pulmonary artery coupling: a functional approach to distinguishing fabry disease from wild-type transthyretin cardiac amyloidosis
Doctor A. Castro Pinto (Guimaraes, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in myocardial disease (1)

The Event

Event poster

Heart Failure 2026

9 May 2026 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Diagnostic and prognostic implications of right ventricular-arterial coupling in cardiac amyloidosis and in genetic and non-genetic cardiomyopathies with hypertrophic phenotype
9 December 2021
thumbnail
Congress Presentation
Right ventricular-pulmonary artery coupling and in-hospital mortality of patients with first acute coronary syndrome
26 August 2023
thumbnail
Congress Presentation
The PA/Ao ratio as a predictor for adverse outcomes in light-chain vs. transthyretin cardiac amyloidosis
1 September 2025
thumbnail
Congress Presentation
Prognostic utility of echocardiographic assessment in wild type transthyretin amyloid cardiomyopathy
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources